Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H HENDERSON

Showing results (491-500 of 547) with videos related to

Pageof 55
Sort By:
Environmental Science and Pollution Research International|April 12, 2019
Performance evaluation of a photochemical model using different boundary conditions over the urban and industrialized metropolitan area of Vitória, BrazilRizzieri Pedruzzi, Bok H Baek, Barron H Henderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
Orphanet Journal of Rare Diseases|May 12, 2025
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United KingdomSara E Mole, Paul Gissen, Shannon Nordstrom, et al.
Clinical and Translational Science|February 9, 2022
A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient settingNathan Stasko, Adam S Cockrell, Jacob F Kocher, et al.
Investigative Ophthalmology & Visual Science|December 7, 2007
An assessment of the apex microarray technology in genotyping patients with Leber congenital amaurosis and early-onset severe retinal dystrophyRobert H Henderson, Naushin Waseem, Rowan Searle, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapyHe J Zhu, Romaine C Nichols, Randal H Henderson, et al.
JAMA Ophthalmology|January 6, 2017
Clinical Characterization of CNGB1-Related Autosomal Recessive Retinitis PigmentosaSarah Hull, Marcella Attanasio, Gavin Arno, et al.
International Journal of Particle Therapy|April 8, 2021
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical ProstatectomyShivam M Kharod, Catherine E Mercado, Christopher G Morris, et al.
International Journal of Particle Therapy|August 7, 2018
Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate CancerDerek T Lee, Nancy P Mendenhall, Tamara L Smith, et al.
International Journal of Particle Therapy|December 4, 2020
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 StudyShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
Pageof 55

Showing results (491-500 of 547) with videos related to

Sort By:
Pageof 55
Environmental Science and Pollution Research International|April 12, 2019
Performance evaluation of a photochemical model using different boundary conditions over the urban and industrialized metropolitan area of Vitória, BrazilRizzieri Pedruzzi, Bok H Baek, Barron H Henderson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
Orphanet Journal of Rare Diseases|May 12, 2025
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United KingdomSara E Mole, Paul Gissen, Shannon Nordstrom, et al.
Clinical and Translational Science|February 9, 2022
A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient settingNathan Stasko, Adam S Cockrell, Jacob F Kocher, et al.
Investigative Ophthalmology & Visual Science|December 7, 2007
An assessment of the apex microarray technology in genotyping patients with Leber congenital amaurosis and early-onset severe retinal dystrophyRobert H Henderson, Naushin Waseem, Rowan Searle, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapyHe J Zhu, Romaine C Nichols, Randal H Henderson, et al.
JAMA Ophthalmology|January 6, 2017
Clinical Characterization of CNGB1-Related Autosomal Recessive Retinitis PigmentosaSarah Hull, Marcella Attanasio, Gavin Arno, et al.
International Journal of Particle Therapy|April 8, 2021
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical ProstatectomyShivam M Kharod, Catherine E Mercado, Christopher G Morris, et al.
International Journal of Particle Therapy|August 7, 2018
Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate CancerDerek T Lee, Nancy P Mendenhall, Tamara L Smith, et al.
International Journal of Particle Therapy|December 4, 2020
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 StudyShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
Pageof 55